Oct 1 (Reuters) - Atrys Health SA ATRY.MC :
* SAYS BUYS INSTITUTO DE ESTUDIOS CELULARES Y MOLECULARES
(ICM), A
GENETIC AND GENOMIC DIAGNOSIS LABORATORY BASED IN SPAIN
* SAYS INCORPORATES THE DEVELOPMENT OF DIAGNOSTIC SERVICES
OF
COVID-19 FROM SALIVA, WITH HIGH SENSITIVITY AND MINIMALLY
INVASIVE, WHICH FACILITATES MASSIVE USE
* SAYS THE INTEGRATION OF ICM WILL PROVIDE WITH NEW GENETIC
PANELS
FOR CANCER DIAGNOSIS, CARDIOVASCULAR, NEUROLOGICAL AND RARE
DISEASES
Source text: https://bit.ly/34cpe5r
Further company coverage: ATRY.MC
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 65 71;))